$1.94 -0.08 (-3.96%)
11/27/2009 1:00 PM

Ligand Pharmaceuticals, Inc. (LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Results 1 - 2 of 2

Recs

0
Member Avatar kurthauer1998 (81.27) Submitted: 5/19/2008 2:22:13 PM : Underperform Start Price: $3.67 LGND Score: +26.54

Appears to have no direction and bad ratios.

Report this Post 0 Comments | Reply | Permalink

Recs

1
Member Avatar ImmortalThanos (65.41) Submitted: 2/28/2008 11:26:10 AM : Underperform Start Price: $3.67 LGND Score: +30.54

Avoid this like the plague. This is another one of those "Jack Of All Trades" companies that never really gets anywhere. Skip this until they get a better mission statement developed.

Report this Post 0 Comments | Reply | Permalink
Results 1 - 2 of 2

Featured Broker Partners